Publications by authors named "Laura York"

Claim this Profile
P
Preventing invasive meningococcal disease in early infancy.
Jessica Presa, Lidia Serra, Catherine Weil-Olivier, Laura York

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Johannes Beeslaar, Susan Mather, Judith Absalon, Joseph J Eiden, Laura J York

Vaccine· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of meningococcal vaccines: considerations for the future.
Hannah Christensen, Hareth Al-Janabi, Pierre Levy, Maarten J Postma, David E Bloom, Laura York

Eur J Health Econ· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination.
Cynthia Burman, Lidia Serra, Charles Nuttens, Jessica Presa, Paul Balmer, Laura York

Hum Vaccin Immunother· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents.
Timo Vesikari, Lars Østergaard, Johannes Beeslaar, Judith Absalon, Joseph J Eiden, Laura J York

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.
Lidia C Serra, Laura J York, Paul Balmer, Chris Webber

J Adolesc Health· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.
Lidia C Serra, Laura J York, Amgad Gamil, Paul Balmer, Chris Webber

Infect Dis Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
Johannes Beeslaar, Judith Absalon, Paul Balmer, Amit Srivastava, Roger Maansson, Laura J York

Vaccine· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine.
John L Perez, Judith Absalon, Johannes Beeslaar, Paul Balmer, Kathrin U Jansen, Laura J York

Expert Rev Vaccines· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination strategies for the prevention of meningococcal disease.
Scott Vuocolo, Paul Balmer, William C Gruber, Kathrin U Jansen, Annaliesa S Anderson, Laura J York

Hum Vaccin Immunother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.
Paul Balmer, Cynthia Burman, Lidia Serra, Laura J York

Hum Vaccin Immunother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.
Paul Balmer, Laura J York

Ther Adv Vaccines Immunother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telephone care co-ordination for tobacco cessation: randomised trials testing proactive versus reactive models.
Scott E Sherman, Paul Krebs, Laura S York, Sharon E Cummins, Ware Kuschner

Tob Control· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
Lars Ostergaard, Timo Vesikari, Judith Absalon, Johannes Beeslaar, Brian J Ward, Laura J York

N Engl J Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Qualitative Evaluation of Web-Based Cancer Care Quality Improvement Toolkit Use in the Veterans Health Administration.
Candice Bowman, Jeff Luck, Randall C Gale, Nina Smith, Laura S York

Qual Manag Health Care· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
Ashesh Gandhi, Paul Balmer, Laura J York

Postgrad Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.
Timo Vesikari, Lars Østergaard, Javier Diez-Domingo, Jacek Wysocki, Carl-Erik Flodmark, Laura J York

J Pediatric Infect Dis Soc· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents.
Timo Vesikari, Jacek Wysocki, Johannes Beeslaar, Joseph Eiden, Qin Jiang, Laura J York

J Pediatric Infect Dis Soc· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents.
Derek Muse, Shane Christensen, Prakash Bhuyan, Judith Absalon, Joseph J Eiden, Laura J York

Pediatr Infect Dis J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.
Shelly Senders, Prakash Bhuyan, Qin Jiang, Judith Absalon, Joseph J Eiden, Laura J York

Pediatr Infect Dis J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults.
Lars Ostergaard, Gregg H Lucksinger, Judith Absalon, Johannes Beeslaar, Joseph Eiden, Laura J York

Vaccine· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.
David M Reiner, Prakash Bhuyan, Joseph J Eiden, John Ginis, Shannon Harris, Laura J York

Vaccine· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a user-driven online quality improvement toolkit for cancer care.
Jeff Luck, Laura S York, Candice Bowman, Randall C Gale, Nina Smith

J Oncol Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimethod evaluation of the VA's peer-to-peer Toolkit for patient-centered medical home implementation.
Jeff Luck, Candice Bowman, Laura York, Amanda Midboe, Thomas Taylor

J Gen Intern Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online toolkits for metric-driven quality improvement: the Veterans Health Administration managed grassroots approach.
Laura York, Bonnie Bruce, Jeff Luck, Candice Bowman, Amanda M Midboe

Jt Comm J Qual Patient Saf· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis